Correlation Between XSpray Pharma and BioArctic
Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and BioArctic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and BioArctic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XSpray Pharma AB and BioArctic AB, you can compare the effects of market volatilities on XSpray Pharma and BioArctic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of BioArctic. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and BioArctic.
Diversification Opportunities for XSpray Pharma and BioArctic
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between XSpray and BioArctic is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and BioArctic AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioArctic AB and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with BioArctic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioArctic AB has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and BioArctic go up and down completely randomly.
Pair Corralation between XSpray Pharma and BioArctic
Assuming the 90 days trading horizon XSpray Pharma AB is expected to under-perform the BioArctic. But the stock apears to be less risky and, when comparing its historical volatility, XSpray Pharma AB is 1.6 times less risky than BioArctic. The stock trades about -0.09 of its potential returns per unit of risk. The BioArctic AB is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 15,850 in BioArctic AB on August 30, 2024 and sell it today you would earn a total of 2,900 from holding BioArctic AB or generate 18.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
XSpray Pharma AB vs. BioArctic AB
Performance |
| Timeline |
| XSpray Pharma AB |
| BioArctic AB |
XSpray Pharma and BioArctic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XSpray Pharma and BioArctic
The main advantage of trading using opposite XSpray Pharma and BioArctic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, BioArctic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioArctic will offset losses from the drop in BioArctic's long position.| XSpray Pharma vs. Xbrane Biopharma AB | XSpray Pharma vs. Hansa Biopharma AB | XSpray Pharma vs. Cantargia AB | XSpray Pharma vs. Vicore Pharma Holding |
| BioArctic vs. Oncopeptides AB | BioArctic vs. Camurus AB | BioArctic vs. Hansa Biopharma AB | BioArctic vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |